Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Untch, Michael; Rezai, Mahdi; Loibl, Sibylle; A. Fasching, Peter; Huober, Jens; Tesch, Hans; Bauerfeind, Ingo; Hilfrich, J.; Eidtmann, Holger; Gerber, Bernd; Hanusch, Claus; Kühn, Thorsten; du Bois, Andreas; Blohmer, Jens‐Uwe; Thomssen, Christoph; Dan Costa, Serban; Jackisch, Christian; Kaufmann, Manfred; Mehta, Keyur; von Minckwitz, Gϋnter

doi:10.1200/jco.2009.23.8451

Public

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Published in Journal of Clinical Oncology • Mar 23, 2010

Authors:

Michael Untch

Mahdi Rezai

Sibylle Loibl

Abstract

PURPOSE Trastuzumab, a humanized antibody against the human epidermal growth factor receptor type 2 (HER2), has shown high efficacy in breast cancer. We prospectively investigated its efficacy given simultaneously with anthracycline-taxane-based neoadjuvant chemotherapy. PATIENTS AND METHODS Patient...

Subject

Trastuzumab

Medicine

Epirubicin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!